VIDEO: IL-17 antagonists continue reshaping psoriasis therapy in 2016
WAIKOLOA, HAWAII – What’s going to be the biggest development in the field of psoriasis in 2016?
Hint: Look for a repeat of 2015.
The first of the interleukin-17 antagonists, secukinumab, was the biggest development of 2015, explained Dr. Craig L. Leonardi, associate clinical professor of...
Source: Skin and Allergy News - Category: Dermatology Source Type: news